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Abstract
Background: Previous studies have evaluated the individual effects of acute myocardial infarction
(AMI) and diabetes mellitus on health-related quality of life outcomes (QOL). Due to the rising
incidence of these comorbid conditions, it is important to examine the synergistic impact of
diabetes mellitus and AMI on QOL.
Methods: In this study, we assessed using several previously validated questionnaires the QOL and
functional status of 96 diabetic patients and 491 non-diabetic patients admitted to Quebec hospital
sites with AMI between 1997 and 1998. We also conducted multivariate analyses to ascertain
whether diabetes mellitus was an independent determinant of SF-36 physical functioning (PCS) and
mental health (MCS) component score QOL outcomes after AMI.
Results: Both patient groups had similar baseline clinical characteristics, but diabetic patients had
slightly higher rates of cardiac risk factors compared to non-diabetics. Overall, QOL measures
were similar between both patient groups at baseline, but diabetic patients reported poorer
functional status than non-diabetic patients. Over the study period, there were significant
differences between the QOL and functional status of diabetic and non-diabetic populations. By one
year, diabetic patients reported poorer QOL outcomes than non-diabetic patients. However,
diabetic patients showed greater improvements in their functional status, but were less likely to
return to work compared to non-diabetic patients. In contrast with these findings, our multivariate
analyses showed that diabetes mellitus was not an independent determinant of QOL and functional
status.
Conclusion: Our study findings suggest that diabetes mellitus is not an independent determinant
of QOL after AMI.
Background
Several clinical studies have shown that acute myocardial
infarction (AMI) causes a decline in the social, physical
and psychological functionality of affected patients [1-
12]. These changes in quality of life (QOL) can impair the
patient's ability to perform even basic daily tasks. Simi-
larly, various studies have found that diabetes mellitus is
also associated with poorer QOL. Both type 1 and type 2
diabetes mellitus have been associated with negative soci-
oeconomic changes, increased morbidity, worsened phys-
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ical capacity and overall declines in general health status
[13-18]. Because diabetes mellitus is so closely associated
with coronary artery disease, it is important to evaluate
the synergistic effect of these conditions on QOL follow-
ing AMI. Clinicians will be able to use this information to
establish appropriate health management strategies for
patients who suffer from both of these diseases.
The purpose of this paper is to measure and compare QOL
outcomes for diabetic and non-diabetic patients who have
sustained a Q-wave or non Q-wave AMI. Specifically, this
paper aims to address 1) whether diabetes mellitus influ-
ences the QOL of post-AMI patients and 2) which QOL
dimensions are most or least affected by the diagnosis of
diabetes mellitus.
Methods
Patient cohort & QOL measurement
From January 1997 to November 1998, 587 Quebec
patients with a confirmed Q wave or non-Q wave AMI
were enrolled in a 1-year prospective cohort study of QOL
after AMI, as detailed previously [19]. Patients who were
eligible for the study were admitted to one of 10 Quebec
hospital sites, were able to read and understand French or
English, and had survived at least 24 hours after hospital
admission. We excluded patients if they were not capable
of giving informed consent or responding to a question-
naire. Diabetic status and additional baseline demo-
graphic and clinical characteristics were determined at the
time of enrollment by a study nurse. A patient was classi-
fied as diabetic based on a description of diabetic status in
chart notes, regular use of antihyperglycemic medications,
and/or laboratory values for Hemoglobin A1C.
We measured changes in patient QOL by means of ques-
tionnaires completed by the patients at baseline admis-
sion, at 30 days, at 6 months, and at 1 year following AMI.
We relied on previously validated questionnaires to assess
the patients' overall health perception, namely the SF-36
health survey [20], a visual analogue scale to rate overall
QOL (range from 0, poorest QOL to 100, best QOL) that
was adopted from Torrance's Feeling Thermometer
[21,22] and the EuroQol measure [23], and a five-level
scale obtained from the National Health Interview Survey
[24]. To measure the patients' functional status, we used
the Duke Activity Status Index (DASI) and a single four-
level question to compare overall functioning before and
after AMI [25]. In addition, each patient reported his or
her level of optimism using another four-level scale to rate
expectations of returning to a normal lifestyle [26]. We
also measured patients' work status and their ability to
return to work using an instrument developed for the
Study of Economics and Quality of Life [27]. As a final
measure of physical and mental functioning, we created a
physical component summary score (PCS) and a mental
component summary score (MCS) as described by Ware et
al [20] by combining the physical components (physical
functioning, role limitations due to physical problems,
bodily pain and vitality) and the mental components
(social functioning, role limitations due to emotional
problems, mental health and general health perceptions)
of the SF-36 subscales.
First, we conducted a univariate analysis to compare the
raw outcomes for diabetic versus non-diabetic patients.
For SF36 scores, differences of 5 points were considered
clinically significant. P-values of <0.05 were considered
statistically significant. A multivariate linear regression
model was then created to obtain adjusted comparisons
of the QOL scores for physical and mental health, and to
isolate any demographic, clinical, and psychosocial base-
line characteristics that influenced patient QOL 1 year
after AMI. Variables that were included in the multivariate
model were: baseline score, diabetes, sex, age, education,
congestive heart failure, previous coronary artery bypass
surgery (CABG), previous percutaneous transluminal cor-
onary angioplasty (PTCA), ventricular fibrillation, recur-
rent ischemia, previous angina, and
hypercholesterolemia. An optimal model was estimated
using backward and forward model selection algorithms
that have been previously described [28].
Results
Baseline characteristics
Of the 587 enrolled patients, we identified 96 (16%) dia-
betic patients and 491 (84%) non-diabetic patients. In
general, the diabetic and non-diabetic patients had simi-
lar demographic and clinical characteristics at baseline,
but there were some clinically significant differences
between the groups (Table 1). At baseline, there was a
higher proportion of women in the diabetic population
compared to the non-diabetic population (33% versus
19%). Diabetic patients also tended to be older than the
non-diabetic patients at enrollment (66 years and 60
years, respectively). In terms of cardiac risk factors, the
diabetic patients had higher rates of angina (34% versus
23%), previous AMI (27% versus 20%), and hypertension
(60% versus 31%) when compared to non-diabetic
patients. Similarly, there were more diabetic patients who
had experienced an AMI of Killip class I or greater (29%
versus 16%, for diabetics and non-diabetics).
For in-hospital procedures received at baseline, there were
several clinically significant differences in the use of revas-
cularization procedures within the two patient popula-
tions (Table 2). Fewer diabetic patients were initially
hospitalized at sites with angiography availability (50%
versus 58%). During baseline hospitalization, fewer dia-
betic patients underwent coronary angioplasty than non-
diabetics regardless of whether or not they were hospital-Health and Quality of Life Outcomes 2005, 3:80 http://www.hqlo.com/content/3/1/80
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ized at sites with angiography availability (15% versus
24%). Diabetic patients were also less often treated with
coronary angioplasty even after undergoing angiography
(36% versus 56%).
Quality of life and medical outcomes
Overall health perception
We obtained complete follow-up QOL measures for over
80% of the study patients (Table 3). In general, diabetic
patients reported lower QOL outcomes than the non-dia-
betic patients for all SF-36 domains at baseline, as well as
after 1 year of follow-up (Table 3). However, when we
analyzed the mean differences between these scores, the
majority of these differences were not clinically significant
(Table 3). Physical functioning was the only dimension
where there was a clinically significant difference, and dia-
betic patients had average scores that were -14.3 points
worse than those for the non-diabetic patients (95% con-
fidence interval [CI] -20.7,-7.8).
Results from the Torrance/EuroQOL Health Perception
Scale indicated that, on average, both diabetic and non-
diabetic patients saw improvements in their overall health
after 1-year of follow-up (Table 4). Nonetheless, the
scores for the diabetic patients were significantly lower
scores than those for the non-diabetic patients at 1 year
(mean difference of -8.7 (95% CI -12.7,-4.6)).
Despite these raw differences in QOL outcomes, multivar-
iate analyses for the physical functioning composite score
(PCS) and the mental health composite score (MCS) at 1
year showed that, after adjustment for baseline prognostic
factors, a diagnosis of diabetes mellitus was not associated
with poorer QOL after AMI (Figure 1). Our models
showed that higher baseline SF-36 scores were associated
with higher PCS and MCS results at 1 year (β-coefficients
of 0.39 (95% CI 0.30, 0.48) and 0.42 (95% CI 0.33, 0.50),
respectively). Level of education and male sex were also
associated with higher PCS scores at 1 year follow-up (β-
coefficients of 0.26 (95% CI 0.06, 0.47) and 3.3 (95% CI
1.1, 5.6), respectively). Increased patient age was associ-
ated with lower PCS results at 1-year (β-coefficient of: -
0.08 (95% CI -0.16, 0.01)). Thus, our multivariate models
suggest that differences in QOL scores at 1 year between
diabetic and non-diabetic patients were confounded by
the lower baseline QOL scores, lower level of education,
higher proportion of women, and increased age of the dia-
betic population.
Functional status
Overall, both patient groups showed modest improve-
ments in their mean DASI outcomes from baseline to 1-
year follow-up (Table 4). At baseline, the mean DASI
score for the non-diabetic group was significantly better
than that of the diabetic group (mean difference of -10.6
(95% CI -14.0, -7.2)). After 1 year of follow-up, both
groups showed modest improvements in their DASI out-
comes and the mean difference decreased to -9.1 (95% CI
-12.3, -5.9). Despite improvements in their DASI scores,
diabetic patients reported poorer functioning than non-
diabetic patients at 1 year following the AMI (51% versus
71% said that they can do anything/almost anything).
Table 2: Use of cardiac procedures for diabetic patients and non-
diabetic patients during baseline hospitalization
Diabetic
N = 96
Non-diabetic
N = 491
Procedures at baseline
Angiography 41 43
Angioplasty 15 24
Bypass surgery 14 7
Revascularization 27 30
Time to angiography (median days) 5 (3,10) 6 (2,10)
Characteristics of angiography
Diseased coronary vessels
None 3 7
One 26 45
Two 33 25
Three 36 20
Left main 10 11
Left ventricular ejection fraction 40 (35,50) 50 (35,60)
Procedure following angiography
Angioplasty 36 56
Bypass surgery 31 15
Values are given as percentages of n except for continuous variables 
for which the inter-quartile ranges are given in parentheses.
Table 1: Demographic and clinical characteristics of diabetic 
patients and non-diabetic patients at baseline hospitalization
Diabetic
N = 96
Non-diabetic
N = 491
Demographic characteristics
Males 67 81
Mean age (years) 66 60
Caucasian race 92 96
Married 68 71
Education (mean years) 10 11
Length of stay (mean days) 10 8
Clinical History
AMI 27 20
Angioplasty 7 6
Bypass surgery 6 7
Cardiac risk factors
Hypertension 60 31
Current smoking 30 42
Hypercholesterolemia 34 37
Characteristics of AMI
Anterior location 36 32
Inferior location 38 43
Lateral location 22 20
Q wave 49 49
Values are given as percentages of n unless otherwise indicated.Health and Quality of Life Outcomes 2005, 3:80 http://www.hqlo.com/content/3/1/80
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For the assessment of patient optimism 1 year after AMI,
there were fewer diabetic patients than non-diabetic
patients who reported optimism about returning to a nor-
mal lifestyle after their AMI (62% versus 68%, respec-
tively). However, both groups showed declines in their
levels of optimism from baseline to 1 year (change of -10
and -8 for diabetics and non-diabetics, respectively).
Work status
For employment status at baseline and at 1 year, fewer
diabetic patients were engaged in full or part-time
employment (14% versus 36% non-diabetics at 1 year).
Multivariate analysis indicated that, when all prognostic
factors included in the SF-36 models were considered, the
number of diabetics who were employed was similar to
the number of employed non-diabetics.
Discussion
The results of our linear regression models suggest that
there is no clinical or statistical significant difference
between the QOL of diabetic and non-diabetic patients
after AMI. Although the diabetic patients reported lower
QOL results than non-diabetics 1-year after AMI, our
regression models for physical functioning and mental
health composite scores showed that these differences
could be attributed to the diabetics' poorer QOL charac-
teristics at baseline. Furthermore, the differences between
QOL scores for the two patient groups were also con-
Table 4: Changes in quality of life for diabetic patients versus non-diabetic patients
Diabetic Non-diabetic
Baseline N = 96 1 year N = 73 Baseline N = 491 1 year N = 418
Health Perception Scale (mean score) 65.1 (60.6,69.5) 65.3 (61.1,69.5) 70.8 (68.9,72.6) 74.0 (72.3,75.6)
Duke activities status index (mean score) 19.4 (16.4,22.3) 20.8 (17.6,23.9) 30.0 (28.3,31.6) 29.9 (28.2,31.6)
General health perception
Good – Excellent 56.2 73.6 67.6 82.5
Fair – Poor 44.8 27.4 32.4 17.5
Abilities to perform tasks
Can do anything/almost anything 56.4 50.7 72.3 70.5
Trouble with some things/anything 45.6 49.3 27.7 29.5
Optimistic about returning to normal health
Strongly agree/Agree 71.7 61.7 75.4 67.9
Disagree/Strongly disagree 5.4 15.0 6.1 10.8
Work status
Full-or part-time work 34.1 14.3 53.3 36.1
Sick leave 2.2 1.4 1.7 3.0
Other 63.7 82.3 45.0 59.0
Values are given as percentages of n unless otherwise indicated.
Table 3: Mean SF-36 score differences between diabetic patients and non-diabetic patients
Baseline N = 587 6 months N = 480 1 year N = 491
Physical functioning -16.7 (-23.1,-10.3) -13.6 (-21.0,-6.2) -14.3 (-20.7,-7.8)
Role-physical -13.1 (-22.7,-3.5) -10.3 (-20.7,0.6) -14.0 (-25.9,-3.2)
Bodily pain -7.2 (-13.5,-0.9) -5.2 (-12.2,1.7) -4.9 (-11.3,1.5)
General health -11.8 (-16.8,-6.7) -7.2 (-12.9,-1.5) -9.3 (-14.9,-3.6)
Vitality -2.5 (-7.5,2.6) -6.0 (-11.7,-0.4) -2.7 (-7.9,2.5)
Social functioning -7.3 (-13.1,-1.6) -7.7 (-14.9,-0.5) -6.4 (-12.3,-0.4)
Role-emotional -4.9 (-14.4,4.6) -8.8 (-19.6,-2.1) -6.1 (-16.6,4.4)
Mental health 0.6 (-4.1,5.3) -0.4 (-5.2,4.4) -2.5 (-8.1,3.1)
Physical component summary (PCS) -6.0 (-8.4,-3.6) -4.6 (-7.5,-1.7) -5.3 (-7.9,-2.7)
Mental component summary (MCS) 0.9 (-1.7,3.5) -1.0 (-3.8,1.8) -0.3 (-3.2,2.6)
Differences are given as the diabetic patient scores minus the non-diabetic patient scores with the 95% confidence intervals in parentheses.
Differences are considered to be clinically significant when the confidence interval laid ±5 units from zero.Health and Quality of Life Outcomes 2005, 3:80 http://www.hqlo.com/content/3/1/80
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founded by the increased age, higher proportion of
women and lower levels of education of the diabetic
patient population.
In general, our diabetic patients had more severe disease
than the non-diabetic patients at baseline. At baseline, the
diabetic patients had more cardiac risk factors (Table 1)
and more extensive coronary artery disease (Table 2) rela-
tive to the non-diabetic patients. Moreover, diabetic
patients were hospitalized for more days than non-dia-
betic patients and had more severe AMI events than the
non-diabetic patients, which suggests that diabetic
patients had more complicated hospital courses than the
non-diabetic patients (Table 1). Of the patients who
underwent cardiac angiography, diabetic patients showed
a higher number of diseased coronary vessels than non-
diabetics (Table 2). Previous studies have shown clinical
characteristics of coronary artery disease are important
determinants of morbidity and mortality after an initial
AMI. However, our regression model did not show any
significant correlations between these clinical characteris-
tics and patient QOL 1 year after AMI (Figure 1).
In our study, diabetic patients received fewer invasive pro-
cedures than non-diabetic patients did following an AMI
event (Table 2). These results are in line with previous
findings which suggest that diabetic patients do not
receive optimal secondary prevention procedures and
medications after an AMI [29]. From our study, it is diffi-
cult to conclude whether these trends in cardiac proce-
dures had an effect on the patients' QOL. Up to now, there
have been conflicting data about the effects of invasive
cardiac procedures on QOL after myocardial infarction.
More recent data from the same authors indicate that car-
diac procedures do not significantly affect QOL 1 year
after AMI [19].
Although it was not assessed in this study, the diabetic
patients' slower rate of return to work may have been asso-
ciated with differences in their baseline demographic and
clinical characteristics. For example, in the older diabetic
population, it is possible that more of the patient had
already reached or were close to the normal age of retire-
ment when their AMI occurred, which would have influ-
enced their decision to return to work. As discussed
earlier, the diabetic patients also tended to have more
severe coronary artery disease characteristics and associ-
ated morbidity than the non-diabetic patients (Tables 1
and 2). These poorer clinical characteristics were likely
confounders that influenced the rate return to work for
the diabetic patient group.
There were several limitations to this study. First, the size
of the diabetic patient group was not very large because
the patients were not recruited based on their diabetic sta-
tus, when the original study was designed. As a result, our
sample sizes are more representative of prevalence of dia-
betes mellitus among patients with ischemic heart dis-
ease. Our sample size was further limited as there were
more diabetic patients than non-diabetic patients who
were lost to follow-up over the study period (27% versus
14%, respectively).
Other limitations to this study were the various demo-
graphic differences between the two patient groups at
baseline. These differences were accounted for as much as
possible in our linear regression model, but it is possible
that we did not include other all the contributory varia-
bles in our model.
Conclusion
Our study findings suggest that a diagnosis of diabetes
mellitus is not an independent determinant of QOL after
AMI. Similar to the non-diabetic patients, the diabetic
patients showed correlations between their QOL and their
baseline scores, age, sex, and level of education.
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Adjusted mean SF-36 score differences between diabetic  patients and non-diabetic patients at 1 year Figure 1
Adjusted mean SF-36 score differences between diabetic 
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